Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemangiosarcoma in dogs and cats.

Annette N Smith1

  • 1Department of Clinical Sciences, Veterinary Teaching Hospital, Wire Road, Auburn University, AL 36849, USA. smith30@auburn.edu

The Veterinary Clinics of North America. Small Animal Practice
|July 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study.

Veterinary medicine and science·2022
Same author

Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression Studies.

Genes·2022
Same author

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients.

Heliyon·2021
Same author

Predictive ability of fine-needle aspirate cytology for incompletely resected mast cell tumor surgical sites.

The Canadian veterinary journal = La revue veterinaire canadienne·2021
Same author

Total laryngectomy and permanent tracheostomy in six dogs.

Veterinary and comparative oncology·2021
Same journal

Regulation of Artificial Intelligence in Veterinary Medicine.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles

Hemangiosarcoma (HSA) is an aggressive cancer in dogs originating from endothelial cells, known for rapid metastasis. Current treatments offer limited survival, prompting research into new therapeutic options for this rare tumor.

Area of Science:

  • Veterinary Oncology
  • Cancer Biology

Background:

  • Hemangiosarcoma (HSA), encompassing angiosarcoma and malignant hemangioendothelioma, is a highly malignant tumor originating from endothelial cells.
  • HSA is characterized by early and aggressive metastasis, posing a significant clinical challenge.
  • While common in dogs, HSA is rare in other species, making canine models crucial for research.

Purpose of the Study:

  • To summarize the current understanding of Hemangiosarcoma (HSA) in dogs.
  • To highlight the challenges in treating this aggressive cancer.
  • To underscore the need for novel therapeutic strategies.

Main Methods:

  • Review of existing literature on canine Hemangiosarcoma.
  • Analysis of treatment modalities including surgery, chemotherapy, and radiation.

Related Experiment Videos

  • Evaluation of prognostic factors and survival data.

    • Main Results:

    • Hemangiosarcoma is a common and aggressive malignancy in dogs, frequently metastasizing early.
    • Standard treatments like surgery and chemotherapy yield short survival times, typically less than one year.
    • Superficial dermal HSAs represent an exception with potentially better prognoses.

    Conclusions:

    • Hemangiosarcoma remains a challenging cancer in veterinary medicine due to its aggressive nature and metastatic potential.
    • Current treatment options provide limited long-term survival for most affected dogs.
    • Ongoing research is essential to develop more effective treatments for Hemangiosarcoma.